Stimulation of Fas signaling down-regulates activity of neutrophils from major trauma patients with SIRS

Immunobiology

Volumn 216, Issue 3, 2011, Pages 334-342

  Paunel Görgülü, Adnana ^a   Lögters, Tim ^a   Flohé, Sascha ^a   Cinatl, Jindrich ^b   Altrichter, Jens ^a   Windolf, Joachim ^a   Scholz, Martin ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Caspases; Chemotaxis; Neutrophils; Oxidative burst; Phagocytosis; SIRS

Indexed keywords

CASPASE; CASPASE INHIBITOR; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 8;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; INJURY SEVERITY; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; CHEMOTAXIS, LEUKOCYTE; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEUTROPHILS; PHAGOCYTOSIS; RESPIRATORY BURST; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WOUNDS AND INJURIES;

EID: 79251594691     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.07.005     Document Type: Article

References (34)

1. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
2. Boatright K.M., Renatus M., Scott F.L., Sperandio S., Shin H., Pedersen I.M., Ricci J.E., Edris W.A., Sutherlin D.P., Green D.R., Salvessen G.S. A unified model for apical caspase activation. Mol. Cell. 2003, 11:529-541.
3. Botha A.J., Moore F.A., Moore E.E., Kim F.J., Banerjee A., Peterson V.M. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery 1995, 118:358-365.
4. Calandra T., Cohen J. International Sepsis Forum Definition of Infection in the ICU Consensus Conference: The International sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit. Care Med. 2005, 33:1538-1548.
5. Chen Y.L., Chen S.H., Wabg J.Y., Yang B.C. Fas ligand on tumor cells mediates inactivation of neutrophils. J. Immunol. 2003, 171:1183-1191.
6. Cinatl, Blaheta R., Bittoova M., Scholz M., Margraf S., Vogel J.U., Cinatl J., Doerr H.W. Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis. J. Immunol. 2000, 165:4405-4413.
7. Edwards S.W. Biochemistry and Physiology of the Neutrophil 1994, Cambridge University Press, New York.
8. Edwards S.W., Hallett M.B. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol. Today 1997, 18:320-324.
9. Fabian T.C., Croce M.A., Stewart R.M., Dockter M.E., Proctor K.G. Neutrophil CD18 expression and blockade after traumatic shock and endotoxin challenge. Ann. Surg. 1994, 220:552-563.
10. Fanning N.F., Kell M.R., Shorten G.D., Kirwan W.O., Bouchier-Hayes D., Cotter T.G., Redmond H.P. Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation. Shock 1999, 11:167-174.
11. Greenspan L., McLellan B.A., Greig H. Abbreviated injury scale and injury severity score: a scoring chart. J. Trauma 1985, 25:60-64.
12. Greenstein S., Barnard J., Zhou K., Fong M., Hendey B. Fas activation reduces neutrophil adhesion to endothelial cells. J. Leukoc. Biol. 2000, 68:715-722.
13. Hagimoto N., Kuwano K., Miyazaki H., Kunitake R., Fujita M., Kawasaki M., Kaneko M., Hara N. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell. Mol. Biol. 1997, 17:272-278.
14. Hasegawa T., Suzuki K., Sakamoto C., Ohta K., Nishiki S., Hino M., Tatsumi N., Kitagawa S. Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia. Blood 2003, 101:1164-1171.
15. Hendey B., Zhu C.L., Greenstein S. Fas activation opposes PMA-stimulated changes in the localization of PKCdelta: a mechanism for reducing neutrophil adhesion to endothelial cells. J. Leukoc. Biol. 2002, 71:863-870.
16. Himpe E., Degaillier C., Coppens A., Kooijman R. Insulin-like growth factor-1 delays Fas-mediated apoptosis in human neutrophils through the phosphatidylinositol-3 kinase pathway. J. Endocrinol. 2008, 199:69-80.
17. Iwai K., Miyawaki T., Takizawa T., Konno A., Ohta K., Yachie A., Seki H., Taniguchi N. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994, 84:1201-1208.
18. Jimenez M.F., William R., Watson G., Parodo J., Evans D., Foster D., Steinberg M., Rotstein O.D., Marshall J.C. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch. Surg. 1997, 132:1263-1270.
19. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., Peter M.E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995, 14:5579-5588.
20. Kotani J., Ayallone N.J., Lin E., Goshima M., Gandhi K., Lowry S.F., Calyano S.E. Fas-mediated neutrophil apoptosis and associated A1 protein expression during systemic inflammation are regulated independently of both tumor necrosis factor receptors. Shock 2003, 19:201-217.
21. Kotone-Miyahara Y., Yamashita K., Lee K.K., Yonehara S., Uchiyama T., Sasada M., Takahashi A. Short-term delay of Fas-stimulated apoptosis by GM-CSF as a result of temporary suppression of FADD recruitment in neutrophils: evidance implicating phosphatidylinositol 3-kinase and MEK1-ERK1/2 pathways downstream of classical protein kinase C. J. Leukoc. Biol. 2004, 110:1047-1056.
22. Liles W.C., Kiener P.A., Ledbetter J.A., Aruffo A., Klebanoff S.J. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 1996, 184:429-440.
23. Maianski N.A., Mul F.P., van Buul J.D., Roos D., Kuijpers T.W. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood 2002, 99:672-679.
24. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Sprung C.L., Sibbald W.J. Multiple Organ Dysfunction Score: a reliable descriptor of a complex clinical outcome. Crit. Care Med. 1995, 23:1638-1652.
25. Marsik C., Halama T., Cardona F., Wlassits W., Mayr F., Pleiner J., Jilma B. Regulation of Fas (APO-1, CD95) and Fas lignad expression in leukocytes during systemic inflammation in humans. Shock 2003, 20:493-496.
26. Muller Kobold A.C., Tulleken J.E., Zijlstra J.G., Sluiter W., Hermans J., Kallenberg C.G., Tervaert J.W. Leukocyte activation in sepsis; correlations with disease state and mortality. Intens. Care Med. 2000, 26:883-892.
27. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139:271-279.
28. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 1993, 364:806-809.
29. Paunel-Görgülü A., Zörnig M., Lögters T., Altrichter J., Rabenhorst U., Cinatl J., Windolf J., Scholz M. Mcl-1 mediated impairement of the intrinsic apoptosis pathway in circulating neutrophils from critically ill patients can be overcome by Fas stimulation. J. Immunol. 2009, 183:6198-6206.
30. Peter M.E., Krammer P.H. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opin. Immunol. 1998, 10:545-551.
31. Peter M.E., Budd R.C., Desbarats J., Hendrick S.M., Hueber A.O., Newell M.K., Owen L.B., Pope R.M., Tschopp J., Wajant H., Wallach D., Wiltrout R.H., Zörnig M., Lynch D.H. The CD95 receptor: apoptosis revisited. Cell 2007, 129:447-450.
32. Pop C., Fitzgerald P., Green D.R., Salvesen G.S. Role of preoteolysis in caspase-8 activation and stabilization. Biochemistry 2007, 46:4398-4407.
33. Savill J.S., Wyllie A.H., Henson J.E., Walport M.J., Henson P.M., Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 1998, 83:865-875.
34. Scholz M., Simon A., Berg M., Schuller A.M., Hacibayramoglu M., Margraf S., Theisen A., Windolf J., Wimmer-Greinecker G., Moritz A. In vivo inhibition of neutrophil activity by a FAS (CD95) stimulating module: arterial in-line application in a porcine cardiac surgery model. J. Thorac. Cardiovasc. Surg. 2004, 127:1735-1742.